Two Sigma Investments, LP Athira Pharma, Inc. Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 425,605 shares of ATHA stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

425,605

Previous 304,071 39.97%

Holding current value

$1.07 Million

Previous $738,000 57.99%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.24 - $4.15 $272,236 - $504,366	121,534 Added 39.97%	425,605 $1.17 Million
Q4 2023 Feb 14, 2024	BUY	$1.39 - $2.46 $51,464 - $91,081	37,025 Added 13.86%	304,071 $738,000
Q3 2023 Nov 14, 2023	SELL	$1.9 - $3.16 $170,325 - $283,278	-89,645 Reduced 25.13%	267,046 $539,000
Q2 2023 Aug 14, 2023	SELL	$2.36 - $3.59 $152,725 - $232,323	-64,714 Reduced 15.36%	356,691 $1.05 Million
Q1 2023 May 15, 2023	BUY	$2.26 - $4.22 $183,213 - $342,106	81,068 Added 23.82%	421,405 $1.05 Million

Q4 2022 Feb 14, 2023	SELL	$2.76 - $3.37 $56,044 - $68,431	-20,306 Reduced 5.63%	340,337 $1.08 Million
Q3 2022 Nov 14, 2022	BUY	$3.12 - $3.96 $256,495 - $325,551	82,210 Added 29.53%	360,643 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$2.74 - $13.43 $575,882 - $2.82 Million	210,176 Added 307.92%	278,433 $849,000
Q1 2022 May 16, 2022	SELL	$8.96 - $13.51 $838,862 - $1.26 Million	-93,623 Reduced 57.83%	68,257 $921,000
Q4 2021 Feb 14, 2022	SELL	$9.17 - $16.39 $562,313 - $1.01 Million	-61,321 Reduced 27.47%	161,880 $2.11 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $11.09 $1.32 Million - $1.6 Million	144,401 Added 183.25%	223,201 $2.09 Million
Q2 2021 Aug 16, 2021	BUY	$10.24 - $20.87 $806,912 - $1.64 Million	78,800 New	78,800 $807,000

Others Institutions Holding ATHA

# of Institutions

Shares Held

22.3M

Call Options Held

77.1K

Put Options Held

42.4K

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $95.3M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Athira Pharma, Inc. Transaction History